Hosted on MSN6mon
Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapyMetabolic dysfunction-associated steatohepatitis (MASH) is one of the most common chronic liver diseases ... inhibit the phagocytosis of F4/80 labeled macrophages and improve the polarization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback